Literature DB >> 16891026

PEI-alginate nanocomposites as efficient in vitro gene transfection agents.

Soma Patnaik1, Anita Aggarwal, Surendra Nimesh, Anita Goel, Munia Ganguli, Neeru Saini, Y Singh, K C Gupta.   

Abstract

The positive charge on PEI was partially shielded by forming ionic nanocomposites with a polysaccharide, alginic acid, in aqueous solution, bypassing tedious chemical synthesis. The content of alginic acid was varied systematically to obtain a series of nanocomposites. The nanocomposites were first characterized by assessing the surface charge (zeta potential), size (DLS) and morphology (AFM) followed by evaluation for their DNA interaction ability, cytotoxicity and transfection efficiency on various cell lines. The transfection efficiency of PEI-alginate (6.26%) nanocomposites improved dramatically (2-16-fold over native PEI) in all the cell lines studied. However, a decrease in transfection efficiency was observed on deviating from this optimal concentration of alginic acid in nanocomposites. Cytotoxicity of PEI-alginate/DNA complexes was nearly abolished on increasing the concentration of alginic acid in nanocomposites. PEI-alginate (6.26%) nanocomposites also delivered SiRNAs efficiently into mammalian cells, resulting in 80% suppression of GFP expression. The cellular uptake and endosomal escape of PEI-alginate nanocomposites and PEI were found to follow a similar route when transfection was carried out in presence of chloroquine, bafilomycin A1, cytochalasin B and methyl-beta-cyclodextrin. The results demonstrate a versatile vector that can be used for efficient cytoplasmic delivery of a broad range of nucleic acids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891026     DOI: 10.1016/j.jconrel.2006.06.025

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

1.  Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine.

Authors:  Peisheng Xu; Griffin K Quick; Yoon Yeo
Journal:  Biomaterials       Date:  2009-07-25       Impact factor: 12.479

2.  Development and characterization of pectinate micro/nanoparticles for gene delivery.

Authors:  Praneet Opanasopit; Auayporn Apirakaramwong; Tanasait Ngawhirunpat; Theerasak Rojanarata; Uracha Ruktanonchai
Journal:  AAPS PharmSciTech       Date:  2008-01-09       Impact factor: 3.246

3.  Pendant polymer:amino-β-cyclodextrin:siRNA guest:host nanoparticles as efficient vectors for gene silencing.

Authors:  Aditya Kulkarni; Kyle DeFrees; Seok-Hee Hyun; David H Thompson
Journal:  J Am Chem Soc       Date:  2012-04-30       Impact factor: 15.419

4.  Efficiency of Cytosolic Delivery with Poly(β-amino ester) Nanoparticles is Dependent on the Effective pKa of the Polymer.

Authors:  Denis Routkevitch; Deepti Sudhakar; Marranne Conge; Mahita Varanasi; Stephany Y Tzeng; David R Wilson; Jordan J Green
Journal:  ACS Biomater Sci Eng       Date:  2020-05-18

5.  Efficiently engineered cell sheet using a complex of polyethylenimine-alginate nanocomposites plus bone morphogenetic protein 2 gene to promote new bone formation.

Authors:  Han Jin; Kai Zhang; Chunyan Qiao; Anliang Yuan; Daowei Li; Liang Zhao; Ce Shi; Xiaowei Xu; Shilei Ni; Changyu Zheng; Xiaohua Liu; Bai Yang; Hongchen Sun
Journal:  Int J Nanomedicine       Date:  2014-05-07

6.  Cross-linked polyethylenimine-tripolyphosphate nanoparticles for gene delivery.

Authors:  Xianzhang Huang; Sujing Shen; Zhanfeng Zhang; Junhua Zhuang
Journal:  Int J Nanomedicine       Date:  2014-10-16

7.  Nischarin-siRNA delivered by polyethylenimine-alginate nanoparticles accelerates motor function recovery after spinal cord injury.

Authors:  Yue-Min Ding; Yu-Ying Li; Chu Wang; Hao Huang; Chen-Chen Zheng; Shao-Han Huang; Yang Xuan; Xiao-Yi Sun; Xiong Zhang
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

Review 8.  Polymeric Systems for Cancer Immunotherapy: A Review.

Authors:  Thai Minh Duy Le; A-Rum Yoon; Thavasyappan Thambi; Chae-Ok Yun
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.